Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer

The Original Article was published on 15 July 2020

Correction to: Nature https://doi.org/10.1038/s41586-020-2481-8Published online 15 July 2020

In this Article, the description for the Supplementary Information file stated: “This file contains Pre-clinical rationale for triaging participants to genotype-matched targeted therapies in the NLMT.”. However, the initial Supplementary Information file uploaded contained only the trial protocol and did not contain the rationale. The Supplementary Information file has now been replaced online, and the description has been updated to read: “This file contains pre-clinical rationale for triaging participants to genotype-matched targeted therapies in the NLMT and Protocol version 8.0, in use on 30 November 2019.”.

In addition, the first four sentences of the Acknowledgements section have been altered to read: ‘The Investigators and Sponsor thank all the patients and their families who participated in this trial, as well as the NHS Trusts and staff and the members of the Trial Steering Committee, chaired by R. Kaplan and including independent members K. Kerr, C. Dick, J. Paul and J. Wason, who supported this trial. We thank our patient and public representatives, M. Baker on the Trial Steering Committee and T. Haswell on the Trial Management Group. We are grateful for the support of the Trial Management Group, including G. Cook, A. Desai, A. Devaraj, D. Fennell, M. Griffiths, S. Janes, S. M. Lee, U. McDermott, A. Nicholson, P. Rehal, S. Subramaniam, P. Taniere, Y. Wallis and D. White and for the support of principal investigators P. Shaw (Velindre Cancer Centre), C. Lewanski and D. Power (Imperial College Healthcare NHS Trust) and S. Danson (Weston Park Cancer Centre). We thank all staff at the Cancer Research UK Clinical Trials Unit for their contributions to the trial, including A. Allen, K. Brock, L. Crack, K. Davies, K. James, S. Mee, I. Nutt and S. Ordish.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Gary Middleton.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Middleton, G., Fletcher, P., Popat, S. et al. Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer. Nature 585, E21 (2020). https://doi.org/10.1038/s41586-020-2656-3

Download citation

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing